journal article·2020-03-19Open access

New Means to Control Molecular Assembly

Jiali Zhang, Hai Yu, Bradley Harris, Yunbo Zheng, Umit Celik, Lan Na, Roland Faller, Xi Chen, Dominik R. Haudenschild, Gang-yu Liu

The Journal of Physical Chemistry C· Volume 124· Issue 11

Abstract

While self-assembly of molecules is relatively well-known and frequently utilized in chemical synthesis and material science, controlled assembly of molecules represents a new concept and approach. The present work demonstrates the concept of controlled molecular assembly using a non-spherical biomolecule, heparosan tetrasaccharide (MW = 1.099 kD). The key to controlled assembly is the fact that ultra-small solution droplets exhibit different evaporation dynamics from those of larger ones. Using an independently controlled microfluidic probe in an atomic force microscope, sub-femtoliter aqueous droplets containing designed molecules produce well-defined features with dimensions as small as tens of nanometers. The initial shape of the droplet and the concentration of solute within the droplet dictate the final assembly of molecules due to the ultrafast evaporation rate and dynamic spatial confinement of the droplets. The level of control demonstrated in this work brings us closer to programmable synthesis for chemistry and materials science which can be used to develop vehicles for drug delivery three-dimensional nanoprinting in additive manufacturing.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Innovative Microfluidic and Catalytic Techniques Innovation · Nanomaterials and Printing Technologies · Nanofabrication and Lithography Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, University of California Davis, Davis, California 95616, United States

Department of Chemical Engineering, University of California Davis, Davis, California 95616, United States

Department of Orthopaedic Surgery, University of California, Davis Medical Center, Sacramento, California 95817, United States

Funding

Lawrence Livermore National Laboratory · Gordon and Betty Moore Foundation · National Institutes of Health · National Science Foundation

References (55)

Show source-provided references
1. 10.1126/science.107082110.1126/science.1070821 ↗
2. 10.1146/annurev.matsci.28.1.15310.1146/annurev.matsci.28.1.153 ↗
3. 10.1021/ja00183a04910.1021/ja00183a049 ↗
4. 10.1021/ja00521a01610.1021/ja00521a016 ↗
5. 10.1021/ja00351a06310.1021/ja00351a063 ↗
6. 10.1126/science.271.5251.97610.1126/science.271.5251.976 ↗
7. 10.1021/ma902680610.1021/ma9026806 ↗
8. 10.1126/science.110286610.1126/science.1102866 ↗
9. 10.1038/nmat161110.1038/nmat1611 ↗
10. 10.1016/s0304-4157(00)00016-210.1016/s0304-4157(00)00016-2 ↗
11. 10.1126/science.275.5300.65110.1126/science.275.5300.651 ↗
12. 10.1021/acs.jpclett.8b0244210.1021/acs.jpclett.8b02442 ↗
13. 10.1039/c1sm06393f10.1039/c1sm06393f ↗
14. 10.1021/cm035256t10.1021/cm035256t ↗
15. 10.1021/la053450j10.1021/la053450j ↗
16. 10.1021/la011470p10.1021/la011470p ↗
17. 10.1002/adom.20130036910.1002/adom.201300369 ↗
18. 10.1021/la702129b10.1021/la702129b ↗
19. 10.1016/0021-9797(77)90396-410.1016/0021-9797(77)90396-4 ↗
20. 10.1016/j.cis.2014.12.00310.1016/j.cis.2014.12.003 ↗
21. 10.4161/bbug.2.1.1420110.4161/bbug.2.1.14201 ↗
22. 10.1016/s0008-6215(02)00219-710.1016/s0008-6215(02)00219-7 ↗
23. 10.1074/jbc.m70159920010.1074/jbc.m701599200 ↗
24. 10.1039/c9bm00443b10.1039/c9bm00443b ↗
25. 10.1016/j.carbpol.2014.03.08410.1016/j.carbpol.2014.03.084 ↗
26. 10.1016/j.ijbiomac.2019.02.13310.1016/j.ijbiomac.2019.02.133 ↗
27. 10.1016/j.ijbiomac.2018.01.13610.1016/j.ijbiomac.2018.01.136 ↗
28. 10.1016/j.ajps.2018.11.00510.1016/j.ajps.2018.11.005 ↗
29. 10.1016/j.ijpharm.2014.07.04510.1016/j.ijpharm.2014.07.045 ↗
30. 10.3390/pharmaceutics1002005710.3390/pharmaceutics10020057 ↗
31. Na, L.; Yu, H.; Ghosh, T.; McArthur, J. B.; Asbell, T.; Chen, X. Engineered P. multocida heparosan synthases improve size-controlled enzymatic synthesis of longer heparosan oligosaccharides. Submitted.
32. 10.3390/molecules1608639610.3390/molecules16086396 ↗
33. 10.1039/c1cc14034e10.1039/c1cc14034e ↗
34. 10.1039/c0cc01381a10.1039/c0cc01381a ↗
35. 10.1039/c4cc10306h10.1039/c4cc10306h ↗
36. 10.1039/c2cc17577k10.1039/c2cc17577k ↗
37. 10.1021/nn900479610.1021/nn9004796 ↗
38. 10.1021/nl080606210.1021/nl0806062 ↗
39. 10.1021/jp406239d10.1021/jp406239d ↗
40. 10.1021/nn303407j10.1021/nn303407j ↗
41. Garno J. C. · 2006 · 10510.1007/3-540-26914-2_3 ↗
42. Tian T. · 2011 · 16710.1007/978-1-4419-9899-6_5 ↗
43. Lifang Shi A. K. · Lett. Appl. NanoBioScience · 2015 · 4 · 316
44. 10.1021/la00001a00510.1021/la00001a005 ↗
45. 10.1021/la00090a01910.1021/la00090a019 ↗
46. 10.1006/jcis.1996.460410.1006/jcis.1996.4604 ↗
47. 10.1016/s0169-4332(01)00958-810.1016/s0169-4332(01)00958-8 ↗
48. 10.1016/s0304-3991(02)00094-310.1016/s0304-3991(02)00094-3 ↗
49. 10.1002/sia.230910.1002/sia.2309 ↗
50. 10.1021/la020697x10.1021/la020697x ↗
51. 10.1021/acs.jpcb.7b0697810.1021/acs.jpcb.7b06978 ↗
52. 10.1021/acs.jpca.8b0341710.1021/acs.jpca.8b03417 ↗
53. 10.1021/nl901384x10.1021/nl901384x ↗
54. 10.1039/c2nr33214k10.1039/c2nr33214k ↗
55. 10.1002/adma.20110237110.1002/adma.201102371 ↗